The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Debt to equity
The Cooper Companies, Inc.'s debt to equity at the end of the quarter to 31 July 2026 was 0.3×, up 0.0× from fiscal 2025 (0.3×). Over the past ten years it has ranged from 0.2× (fiscal 2021) to 0.6× (fiscal 2018); the current reading is higher than 18% of that period. That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.3× | (4.85%) |
| FY2024 | 0.3× | (6.06%) |
| FY2023 | 0.3× | (11.68%) |
| FY2022 | 0.4× | 80.59% |
| FY2021 | 0.2× | (54.50%) |
| FY2020 | 0.5× | (6.85%) |
| FY2019 | 0.5× | (17.69%) |
| FY2018 | 0.6× | 65.58% |
| FY2017 | 0.4× | (25.35%) |
| FY2016 | 0.5× | (1.96%) |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jul 2026 | 0.3× | 2.31% |
| Apr 2026 | 0.3× | (0.10%) |
| Jan 2026 | 0.3× | (1.71%) |
| Oct 2025 | 0.3× | 2.49% |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALGN Align Technology, Inc. compare | 0.0× |
| RGEN Repligen Corporation compare | 0.3× |
| COO The Cooper Companies, Inc. | 0.3× |
| ATR AptarGroup, Inc. compare | 0.5× |
| AVTR Avantor, Inc. compare | 0.7× |
| BLCO Bausch + Lomb Corporation compare | 0.8× |
| TFX Teleflex Incorporated compare | 1.0× |
| SOLV Solventum Corporation compare | 1.1× |
| BAX Baxter International Inc. compare | 1.5× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement